Targeting SOCS-3 expression and PTPs activity using appropriate inhibitors and implying ER stress reducing measures could help in reversing leptin insensitivity in obesity. This evidence concerns the gene SOCS3 and obesity due to melanocortin 4 receptor deficiency.